Vyriad Inc. Announces Development of a New Antibody Test to Determine Protective Immunity From COVID-19

NEXT STORY
How IoT is Transforming the Pharma to Physician Relationship
PREV STORY
Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Geron Appoints Vice President, Pharmacovigilance and Drug Safety

MENLO PARK, Calif., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today ...

author_avatar
NASDAQ Market News

Histogenics Corporation Announces Third Quarter 2018 Financial and Operating Results

WALTHAM, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- ‒ Histogenics and FDA Continue Discussions ...

author_avatar
NASDAQ Market News

Status of the Market Authorisation Application of Apealea in the European Union

Oasmia Pharmaceutical AB hereby issues a notification that contrary to what was anticipated in ...

author_avatar
NASDAQ Market News